May 1, 2017 by Brian Orelli, PhDIDEXX Laboratories, Inc. Earnings: Solid Revenue and Earnings GrowthManagement is raising revenue guidance for the year.
May 1, 2017 by Brian Orelli, PhDVertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next GenerationSales of the biotech's cystic fibrosis drugs continue to grow as it develops next-generation drugs to treat more patients.
May 1, 2017 by Brian Orelli, PhDSeattle Genetics, Inc. Earnings: Solid Quarter, but Investors WaitValue-driving events won't come until the second half of the year or beyond.
Apr 28, 2017 by Brian Orelli, PhDCelgene Corporation Earnings: Trading Price for VolumeThe move could pay off, but first-quarter results suffered because of it.
Apr 28, 2017 by Brian Orelli, PhDWhy athenahealth, Inc Stock Got Hammered TodayFirst-quarter earnings were not what the doctor ordered.
Apr 27, 2017 by Brian Orelli, PhDNatus Medical Inc: This BABY Has Some Growing PainsIt was a rough quarter for the medical device and services company.
Apr 27, 2017 by Brian Orelli, PhDBaxter International Inc. Continues to Cut Costs and Grow the Bottom LineThe medical supply company turned in another outstanding quarter.
Apr 27, 2017 by Brian Orelli, PhDWhy CryoLife Inc. Jumped HigherThe medical device and tissue processing company reports a solid first quarter.
Apr 26, 2017 by Brian Orelli, PhDBiogen Inc. Earnings: New Drug Sparks LifeSpinraza launch is off to a good start.
Apr 26, 2017 by Brian Orelli, PhDWhy Natus Medical Inc. Sank TodayIt was a rough first quarter for the medical device and services company.
Apr 25, 2017 by Brian Orelli, PhDWhy TG Therapeutics Inc. Jumped Higher TodayAn analyst initiation and upcoming data sends shares of the biotech higher.
Apr 25, 2017 by Brian Orelli, PhD3 Things You Didn't Know About bluebird bio, Inc.Going beyond LentiGlobin and CAR-T.
Apr 21, 2017 by Brian Orelli, PhDWhy Immunomedics, Inc. Got Hammered TodaySometimes it's what a company doesn't do that matters.
Apr 21, 2017 by Brian Orelli, PhDWhy XBiotech Inc. Got Crushed TodayA European approval seems unlikely.
Apr 20, 2017 by Brian Orelli, PhDWhy ImmunoGen, Inc. Jumped Higher TodaySentiment takes over the biotech's share price.
Apr 20, 2017 by Brian Orelli, PhDThe Top Gene-Sequencing Stock to Buy in 2017Illumina is investors' best buy in this category.
Apr 20, 2017 by Brian Orelli, PhDHere's Why the Best Is Yet to Come for Exelixis, Inc.There's more upside left in this biotech.
Apr 19, 2017 by Brian Orelli, PhDWhy ImmunoGen, Inc. Shot Up TodayAn analyst upgrade spurs shares higher.
Apr 18, 2017 by Brian Orelli, PhDWhy Cytokinetics, Inc. Jumped Higher TodayThe biotech will join the S&P SmallCap 600 index.
Apr 13, 2017 by Brian Orelli, PhDHere's Why the Best Is Yet to Come for Ionis Pharmaceuticals, Inc.A pipeline of drugs has this biotech poised for further success.
